Antibody therapeutics for Alzheimer’s disease: an interview with Jeffrey Cummings

Written by Jeffrey Cummings (Cleveland Clinic Lou Ruvo Center for Brain Health, NV, USA)

Jeffrey Cummings is a neurologist/clinical trialist and is the Vice Chair for Research in the Department of Brain Health at the University of Nevada, Las Vegas (NV, USA). He is also the Director of the Center for Neurodegeneration and Translational Neuroscience at the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas. Dr Cummings is extremely interested in drug development for treatments into neurodegenerative disorders, particularly surrounding treatments for symptomatic aspects of the disease, including cognition and behavioral disturbances, as well as disease-modifying approaches to the treatment of neurodegenerative diseases. In this interview, Dr Cummings speaks to us...

To view this content, please register now for access

It's completely free